Health

China Medical University Hospital, Collaborated with Microsoft Taiwan, Launched GenAI: gHi System

gHi system is the world's first GenAI medical record system in Mandarin and reduce time spent by 75% TAICHUNG, Taiwan, April 2, 2024 /PRNewswire/ -- China Medical University Hospital (CMUH) and Microsoft Taiwan announced the Generative Healthcare Intelligent (gHi) System, which is being applied...

2024-04-02 20:30 1963

Innovating "Treadmill Exercise Test AI-Assisted Interpretation System," CMUH(Taiwan) Timely Saves More Patients with Severe Myocardial Infarction

TAICHUNG, Taiwan, April 2, 2024 /PRNewswire/ -- The treadmill exercise test (TET) is an important tool for diagnosing coronary artery disease (CAD), but limited by time spent for the manual interpretation of a dozen charts and the challenges in identifying minor deviations. Traditionally, manual ...

2024-04-02 20:30 1464

China Medical University Hospital Develops "AISIA" to Diagnose Acute Ischemic Stroke in 90 Seconds to Assist Doctors in Making Medical Decisions

TAICHUNG, Taiwan , April 2, 2024 /PRNewswire/ -- The Neurology Department of China Medical University Hospital (CMUH,Taiwan), teaming up with AI Center at CMUH, has established the AISIA (Artificial Intelligence for Stroke Image Analysis) platform, which contains the "NCCT-based Ischemic Stroke D...

2024-04-02 20:30 1268

Cognex Launches the World's First 3D Vision System with AI

AI-powered 3D vision system offers fast deployment and reliable inspections for manufacturing automation NATICK, Mass., April 2, 2024 /PRNewswire/ -- Cognex Corporation (NASDAQ: CGNX), the leader in industrial machine vision, today released the In-Sight® L38 3D Vision System, which combines AI, ...

2024-04-02 20:30 2107

First Patient Dosed in Clinical Trial of YOLT-101 for the Treatment of FH

SHANGHAI, April 2, 2024 /PRNewswire/ -- YolTech Therapeutics announced that the first patient has been dosed with YOLT-101, the company'sin vivo genome editing candidate being developed as a single dose, potentially curative therapy for Familial Hypercholesterolemia(FH), marking the commencement ...

2024-04-02 20:00 1104

Origin Agritech Provides First Half Revenue Forecast and Updates Advancements in Hybrids and GMO Development

Estimated Revenue Growth of 30-40% in the First Half of FY 2024 Two New Hybrids Completed National Trials and Four GMO Corn Hybrids Currently in National Trials BEIJING, April 2, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural ...

2024-04-02 19:30 2862

CONCEPT MEDICAL RECEIVES US FDA IDE APPROVAL FOR MAGICTOUCH AVF INDICATION, THEIR FIFTH US CLINICAL STUDY APPROVAL FOR THE MAGICTOUCH PORTFOLIO

TAMPA, Fla., April 2, 2024 /PRNewswire/ -- Concept Medical has been granted 'IDE Approval' from the U.S. Food and Drug Administration (FDA) for MagicTouch AVF, its Sirolimus drug-coated balloon (DCB) catheter, to initiate a clinical study for the treatment of stenotic lesions of Arteriovenous Fis...

2024-04-02 17:33 2134

Gushengtang Releases 2023 Annual Results: Sustained Growth with Robust Profit Increase

GUANGZHOU, China, April 2, 2024 /PRNewswire/ -- On March 27th, Gushengtang announced its financial results for 2023. During the year, the company's revenue reached2.323 billion yuan, marking a 43% year-over-year increase; the adjusted net profit was305 million yuan, increased by 53.6% compared to...

2024-04-02 16:49 2865

Grown Alchemist Completes Change of Ownership

The beauty brand moves to privately held ownership to accelerate growth and drive development in key markets includingNorth America and China HONG KONG, April 2, 2024 /PRNewswire/ -- Grown Alchemist , an award-winning biological beauty brand for the design conscious,...

2024-04-02 16:01 1505

AXA launches IncomeBliss Qualifying Deferred Annuity Policy

Empowering retirement planning with dementia advance benefits and the flexibility to choose between cash payouts or reinvestment of annuities Successful applicants can enjoy exclusive subscription to the 5-Year GoalSaver with up to 4.8% p.a. guaranteed returns upon maturity[1] HONG KONG, April 2...

2024-04-02 15:17 1412

European Wellness Shines at AMWC 2024 in Monaco, with Prof. Dr Mike Chan and Prof. Dr Roni Moya as Faculty's Stem Cells Speakers

MONTE CARLO, Monaco, April 2, 2024 /PRNewswire/ -- The European Wellness Biomedical Group (EWBG), a global pioneer in biotechnology and bioregenerative medicine, is pleased to announce its extraordinary participation in the 22nd Aesthetic & Anti-Ageing Medicine World Congress (AMWC) 2024, which w...

2024-04-02 14:16 1645

Innovent and HUTCHMED Jointly Announce NDA Acceptance in China for Sintilimab Combination with Fruquintinib for the Treatment of Advanced Endometrial Cancer with Priority Review Status

ROCKVILLE, Md. and SUZHOU, China, April 2, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune,...

2024-04-02 13:00 1880

Moneymax partners with FWD Life Insurance to empower Filipinos in making better financial decisions

FWD Life Insurance's diverse portfolio of insurance products are now available on Moneymax for easy purchase MANILA, Philippines, April 2, 2024 /PRNewswire/ -- Moneymax, the Philippines' largest personal finance marketplace for financial products and a subsidiary of MoneyHero Limited

2024-04-02 11:54 2931

Fosun International: Total Revenue for 2023 Reached RMB198.2 billion, Industrial Operation Profit Increased by 20% YoY

HONG KONG and SHANGHAI, April 2, 2024 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International"), together with its subsidiaries ("Fosun" or the "Group"), today announced its annual results for the year ended31 December 2023 (the "Reporting Period"). During the R...

2024-04-02 11:31 2988

Kemwell BioPharma Drives Quality Excellence with Veeva Vault QMS

Pioneering biologics CDMO rapidly adopts Veeva Vault QMS to advance development and manufacturing operations BANGALORE, India, April 2, 2024 /PRNewswire/ -- Veeva Systems  (NYSE: VEEV) today announced that Kemwell BioPharma, India's largest biologics contract developmen...

2024-04-02 10:30 1613

InsureMO partners with MoneyHero Group to create the premiere digital insurance aggregation and comparison platform in Greater Southeast Asia

SINGAPORE, April 2, 2024 /PRNewswire/ -- InsureMO is thrilled to announce its strategic partnership with MoneyHero Limited (NASDAQ: MNY) to create the premiere digital insurance aggregation and comparison platform inGreater Southeast Asia. InsureMO's cutting-edge middleware platform has been s...

2024-04-02 10:00 2980

23WELL, THE health supplement brand on the watch

LOS ANGELES, April 1, 2024 /PRNewswire/ -- Just earlier last month, the highly anticipated Natural Products Expo West 2024 concluded successfully inAnaheim, CA. As one of the world's largest leading health and nutrition exhibition, it hosted more than 65,000 registered attendees and 3,000+ exhibi...

2024-04-02 09:07 1679

Oncoclínicas&Co has revenues of R$6 billion and profit of R$313 million in 2023

Increase in the number of patients treated and gains in operational efficiency explain record results SÃO PAULO, April 2, 2024 /PRNewswire/ -- Oncoclínicas&Co (B3: ONCO3) – the largest group dedicated to cancer treatment inLatin America – reported a 35.1% growth in its gross revenue in 2023, tot...

2024-04-02 00:38 1615

Lunit to Showcase 7 Studies at AACR 2024: Unveiling AI Innovations in HER2 Expression-Mutation Analysis and CNTN4 Biomarker Identification

- Lunit's AACR 2024 presentations to spotlight HER2 mutation insights and CNTN4's role in immunotherapy success, pioneering next-gen personalized treatment approaches, supported by the AI-powered Lunit SCOPE suite SEOUL, South Korea, April 1, 2024 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading...

2024-04-01 21:00 1542

ThinkCyte advances biopharma phenotypic drug discovery programs with publication and presentation milestones

TOKYO, April 1, 2024 /PRNewswire/ -- ThinkCyte today announced the publication of apaper in the March issue of Cell Reports Methods on a new method for high-throughput drug discovery. Together with a joint research group including investigators at theUniversity of Tokyo and the University of Brit...

2024-04-01 21:00 1715
1 ... 11121314151617 ... 820